Rare Disease Genetic Testing Market By Disease Type, By Technology, By Specialty, By End User and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis and Forecast $yearF$

Overview

Rare Disease Genetic Testing Market Overview:

According to FutureWise analysis the market for Rare Disease Genetic Testing in 2023 is US$ 1.01 billion, and is expected to reach US$ 2.98 billion by 2031 at a CAGR of 14.50%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Rare Disease Genetic Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Rare Disease Genetic Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Rare Disease Genetic Testing Market:

Quest Diagnostics Inc.
Centogene N.V.
Invitae Corporation
3billion, Inc.
Arup Laboratories
Eurofins Scientific
Strand Life Sciences
Ambry Genetics
Perkin Elmer, Inc.
Macrogen, Inc.
Baylor Genetics
Color Genomics, Inc.
Health Network Laboratories
Preventiongenetics
Progenity, Inc.
Coopersurgical, Inc.
Fulgent Genetics Inc.
Myriad Genetics, Inc.
Laboratory Corporation Of America Holdings
Opko Health, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Rare Disease Genetic Testing Market Segmentation:

By Disease Type

Neurological Disorders
Immunological Disorders
Hematology Diseases
Endocrine and Metabolism Diseases
Cancer
Musculoskeletal Disorders
Cardiovascular Disorders (CVDs)
Dermatology Disease
Others

By Technology

Next-Generation Sequencing (NGS)
- Whole Exome Sequencing (WES)
- Whole Genome Sequencing (WGS)
Array Technology
PCR-based Testing
FISH
Sanger Sequencing
Karyotyping

By Specialty

Molecular Genetic Tests
Chromosomal Genetic Tests
Biochemical Genetic Tests

By End User

Research Laboratories and CROs
Diagnostic Laboratories
Hospitals and Clinics

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the Rare Disease Genetic Testing Market By Disease Type, By Technology, By Specialty, By End User and By Region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
To record and evaluate competitive landscape mapping- Disease Type launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

1. Market Introduction
- 1. Objectives of the Study
  2. Market Definition
  3. Market Scope
  3.1. Years Considered for the Study
  3.2. Market Covered
  4. Currency
  5. Limitations
  6. Stakeholders
2. Research Methodology
- 1. Research Data
  1.1. Secondary Data
  1.1.1. Key Data from Secondary Sources
  1.2. Primary Data
  1.2.1. Key Data from Primary Sources
  2. Market Size Estimation
  3. Market Breakdown and Data Triangulation
  4. Assumptions for the Study
3. Executive Summary
- 1. Market Outlook
  2. Segment Outlook
  3. Competitive Insights
4. Rare Disease Genetic Testing Market Variables, Trends and Scope
- 1. Market Lineage Outlook
  2. Penetration and Growth Prospect Mapping
  3. Industry Value Chain Analysis
  4. Cost Analysis Breakdown
  5. Technology Overview
  6. Regulatory Framework
  6.1. Reimbursement Framework
  6.2. Standards and Compliances
5. Market Overview
- 1. Market Dynamics
  1.1. Market Driver Analysis
  1.1.1. Increasing focus of Rare Disease Genetic Testing Market Companies on Brand Protection
  1.1.2. Untapped Opportunities in Emerging Regions
  1.2. Market Restraint Analysis
  1.2.1. High Cost Associated with Implementation of Predictive Analysis
  1.3. Industry Challenges
  1.3.1. Presence of Ambiguous Regulatory Framework
6. Rare Disease Genetic Testing Market Analysis Tools
- 1. Industry Analysis - Porter’s
  1.1. Supplier Power
  1.2. Buyer Power
  1.3. Substitution Threat
  1.4. Threat from New Entrants
  1.5. Competitive Rivalry
  2. Pestel Analysis
  2.1. Political Landscape
  2.2. Environmental Landscape
  2.3. Social Landscape
  2.4. Technology Landscape
  2.5. Legal Landscape
  3. Major Deals And Strategic Alliances Analysis
  3.1. Joint Ventures
  3.2. Mergers and Acquisitions
  3.3. Licensing and Partnership
  3.4. Technology Collaborations
  3.5. Strategic Divestments
  4. Market Entry Strategies
  5. Case Studies
7. Rare Disease Genetic Testing Market, By Disease Type Historical Analysis and Forecast 2025-2033 (USD Million)
- 1. Neurological Disorders
  2. Immunological Disorders
  3. Hematology Diseases
  4. Endocrine and Metabolism Diseases
  5. Cancer
  6. Musculoskeletal Disorders
  7. Cardiovascular Disorders (CVDs)
  8. Dermatology Disease
  9. Others
8. Rare Disease Genetic Testing Market, By Technology Historical Analysis and Forecast 2025-2033 (USD Million)
- 1. Next-Generation Sequencing (NGS)
  1.1. Whole Exome Sequencing (WES)
  1.2. Whole Genome Sequencing (WGS)
  2.Array Technology
  3.PCR-based Testing
  4.FISH
  5.Sanger Sequencing
  6.Karyotyping
9. Rare Disease Genetic Testing Market, By Specialty Historical Analysis and Forecast 2025-2033 (USD Million)
- 1. Molecular Genetic Tests
  2. Chromosomal Genetic Tests
  3. Biochemical Genetic Tests
10. Rare Disease Genetic Testing Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)
- 1. Research Laboratories and CROs
  2. Diagnostic Laboratories
  3. Hospitals and Clinics
11. North America Rare Disease Genetic Testing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
  2.1. U.S.A
  2.2. Canada
  2.3. Mexico
  3. Market Size (USD Million) Forecast for North America 2025-2033
12. Latin America Rare Disease Genetic Testing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
  2.1. Brazil
  2.2. Venezuela
  2.3. Argentina
  2.4. Rest of Latin America
  3. Market Size (USD Million) Forecast for Latin America 2025-2033
13. Europe Rare Disease Genetic Testing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
  2.1. Germany
  2.2. U.K
  2.3. France
  2.4. Italy
  2.5. Spain
  2.6. Russia
  2.7. Poland
  2.8. Rest of Europe
  3. Market Size (USD Million) Forecast for Europe 2025-2033
14. Asia Pacific Rare Disease Genetic Testing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
  2.1. Japan
  2.2. China
  2.3. India
  2.4. Australia and New Zealand
  2.5. ASEAN
  2.6. Rest of Asia Pacific
  3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033
15. Middle East and Africa Rare Disease Genetic Testing Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
- 1. Introduction
  2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
  2.1. GCC
  2.2. Israel
  2.3. South Africa
  2.4. Rest of MEA
  3. Market Size (USD Million) Forecast for MEA 2025-2033
16. Market Share Analysis and Competitive Landscape
- 1. Global Landscape - Key Players, Revenue and Presence
  2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
  3. Global Emerging Companies
  4. North America - Market Share Analysis and Key Regional Players
  5. Europe - Market Share Analysis and Key Regional Players
  6. Asia Pacific - Market Share Analysis and Key Regional Players
  7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
- 1. Quest Diagnostics Inc.
  1.1. Company Overview
  1.2. Disease Type Portfolio
  1.3. SWOT Analysis
  1.4. Financial Overview
  1.5. Strategic Overview
  2. Centogene N.V.
  2.1. Company Overview
  2.2. Disease Type Portfolio
  2.3. SWOT Analysis
  2.4. Financial Overview
  2.5. Strategic Overview
  3. Invitae Corporation
  3.1. Company Overview
  3.2. Disease Type Portfolio
  3.3. SWOT Analysis
  3.4. Financial Overview
  3.5. Strategic Overview
  4. 3billion, Inc.
  4.1. Company Overview
  4.2. Disease Type Portfolio
  4.3. SWOT Analysis
  4.4. Financial Overview
  4.5. Strategic Overview
  5. Arup Laboratories
  5.1. Company Overview
  5.2. Disease Type Portfolio
  5.3. SWOT Analysis
  5.4. Financial Overview
  5.5. Strategic Overview
  6. Eurofins Scientific
  6.1. Company Overview
  6.2. Disease Type Portfolio
  6.3. SWOT Analysis
  6.4. Financial Overview
  6.5. Strategic Overview
  7. Strand Life Sciences
  7.1. Company Overview
  7.2. Disease Type Portfolio
  7.3. SWOT Analysis
  7.4. Financial Overview
  7.5. Strategic Overview
  8. Ambry Genetics
  8.1. Company Overview
  8.2. Disease Type Portfolio
  8.3. SWOT Analysis
  8.4. Financial Overview
  8.5. Strategic Overview
  9. Perkin Elmer, Inc.
  9.1. Company Overview
  9.2. Disease Type Portfolio
  9.3. SWOT Analysis
  9.4. Financial Overview
  9.5. Strategic Overview
  10. Macrogen, Inc.
  10.1. Company Overview
  10.2. Disease Type Portfolio
  10.3. SWOT Analysis
  10.4. Financial Overview
  10.5. Strategic Overview
  11. Baylor Genetics
  11.1. Company Overview
  11.2. Disease Type Portfolio
  11.3. SWOT Analysis
  11.4. Financial Overview
  11.5. Strategic Overview
  12. Color Genomics, Inc.
  12.1. Company Overview
  12.2. Disease Type Portfolio
  12.3. SWOT Analysis
  12.4. Financial Overview
  12.5. Strategic Overview
  13. Health Network Laboratories
  13.1. Company Overview
  13.2. Disease Type Portfolio
  13.3. SWOT Analysis
  13.4. Financial Overview
  13.5. Strategic Overview
  14. Preventiongenetics
  14.1. Company Overview
  14.2. Disease Type Portfolio
  14.3. SWOT Analysis
  14.4. Financial Overview
  14.5. Strategic Overview
  15. Progenity, Inc.
  15.1. Company Overview
  15.2. Disease Type Portfolio
  15.3. SWOT Analysis
  15.4. Financial Overview
  15.5. Strategic Overview
  16. Coopersurgical, Inc.
  16.1. Company Overview
  16.2. Disease Type Portfolio
  16.3. SWOT Analysis
  16.4. Financial Overview
  16.5. Strategic Overview
  17. Fulgent Genetics Inc.
  17.1. Company Overview
  17.2. Disease Type Portfolio
  17.3. SWOT Analysis
  17.4. Financial Overview
  17.5. Strategic Overview
  18. Myriad Genetics, Inc.
  18.1. Company Overview
  18.2. Disease Type Portfolio
  18.3. SWOT Analysis
  18.4. Financial Overview
  18.5. Strategic Overview
  19. Laboratory Corporation Of America Holdings
  19.1. Company Overview
  19.2. Disease Type Portfolio
  19.3. SWOT Analysis
  19.4. Financial Overview
  19.5. Strategic Overview
  20. Opko Health, Inc.
  20.1. Company Overview
  20.2. Disease Type Portfolio
  20.3. SWOT Analysis
  20.4. Financial Overview
  20.5. Strategic Overview
18. Pre and Post COVID-19 Impact
- 1. Positive influence on the healthcare industry
  2. The financial disruption of the manufacturing sector
  3. Impact of COVID-19 on emerging companies
  4. Significant mandates in the healthcare regulations initiated by administrations
  5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client

Data Pack license: Data Pack license: $1250

Single user license: Single user license: $2850

Multi user license: Multi user license: $3850

Corporate license: Corporate license: $5000

Ask for Discount

Buy Now

Customize This Report

Partner

Report Overview

Table of Contents

List of Tables

List of figures

Overview

Rare Disease Genetic Testing Market Overview:

Major players included in the Rare Disease Genetic Testing Market:

Rare Disease Genetic Testing Market Segmentation:

Competitive Landscape:

FutureWise Key Takeaways:

Objectives of the Study:

Flexible Delivery Model:

Table of Contents

Report Overview

Table of Contents

List of Tables

List of figures

Need Assistance

What you get

What's included

Our Clients